
Oragenics OGEN
$ 0.69
1.21%
Annual report 2025
added 03-16-2026
Oragenics PEG Ratio 2011-2026 | OGEN
Annual PEG Ratio Oragenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000446 | -0.00004 | -0.000485 | -0.00149 | -0.00017 | - | -0.0208 | -0.0332 | -0.118 | -0.0865 | 0.0322 | -0.0691 | -0.275 | -0.0983 | -0.165 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.0322 | -0.275 | -0.0597 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Akari Therapeutics, Plc
AKTX
|
13.5 | $ 5.14 | 11.87 % | $ 346 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.9 | 4.56 % | $ 9.38 B | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 319.85 | -4.06 % | $ 41.9 B | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Aligos Therapeutics
ALGS
|
0.0282 | $ 7.58 | 2.1 % | $ 74.9 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 21.82 | 0.65 % | $ 1.02 B | ||
|
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 4.71 | -0.63 % | $ 766 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 101.59 | 2.13 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 3.49 | 2.69 % | $ 351 M | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.07 | -3.15 % | $ 5.05 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-0.000085 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.02 | $ 1.37 | -11.94 % | $ 352 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.28 | 0.94 % | $ 458 M | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.04 | -2.2 % | $ 3.06 B | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.59 | 6.81 % | $ 423 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-0.00335 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
1.27 | $ 33.68 | -0.56 % | $ 2.24 B | ||
|
bluebird bio
BLUE
|
0.0148 | - | - | $ 546 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.000003 | $ 2.75 | - | $ 1.22 M |